Table: Torii Pharmaceutical - 6-MTH parent results
Jul 27 (Reuters)-
Torii Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Jun 30, 2017 Jun 30, 2016 Dec 31, 2017
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 30.09 29.01 63.10
(+3.7 pct) (-1.4 pct) (+4.8 pct)
Operating 2.37 2.22 5.30
(+7.0 pct) (-9.9 pct) (+38.8 pct)
Recurring 2.41 2.29 5.40
(+5.3 pct) (-9.9 pct) (+35.0 pct)
Net 1.76 1.48 3.90
(+18.7 pct) (-9.1 pct) (+37.3 pct)
EPS 62.78 yen 52.43 yen 139.04 yen
Ann Div 48.00 yen 48.00 yen
-Q2 div 24.00 yen 24.00 yen
-Q4 div 24.00 yen 24.00 yen
NOTE - Torii Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4551.T
((Tokyo Headline News Desk +813 6441 1812))
Recent news on Torii Pharmaceutical Co
See all newsTable: Torii Pharmaceutical - 6-MTH parent results
Brief: Torii Pharmaceutical Co Ltd Says It Will Retire Treasury Shares Worth 2.39% Of Outstanding Stock On Aug 29
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Drugmaker Shionogi to buy Japan Tobacco's unit Torii Pharmaceutical for $1 billion (updated)